Narcolepsy Drugs Global Market Report 2024

Description

Narcolepsy is a chronic neurological condition that disrupts the brain's ability to regulate sleep-wake cycles. Individuals affected by narcolepsy commonly experience extreme daytime drowsiness and uncontrollable episodes of sleep during daytime activities. These episodes can happen at any time. Cataplexy, characterized by a sudden weakening of muscles triggered by intense emotions, often accompanies narcolepsy.

There are two primary types of narcolepsy, type 1 (NT1) and type 2. Type 1 narcolepsy is distinguished by excessive daytime sleepiness and cataplexy. Treatment typically involves medications such as antidepressants, stimulants, and sodium oxybate. Diagnosis usually involves polysomnography and multiple sleep latency tests. Narcolepsy management involves various healthcare settings, including hospitals and retail pharmacies.

The narcolepsy market research report is one of a series of new reports from The Business Research Company that provides narcolepsy market statistics, including narcolepsy industry global market size, regional shares, competitors with a narcolepsy market share, detailed narcolepsy market segments, market trends and opportunities, and any further data you may need to thrive in the narcolepsy industry. This narcolepsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcolepsy market size has grown rapidly in recent years. It will grow from $3.19 billion in 2023 to $3.56 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period can be credited to heightened awareness of narcolepsy, advancements and refinement of diagnostic tools, introduction of new pharmaceutical treatments, increased investments in research and development, and enhanced initiatives for patient education.

The narcolepsy market size is expected to see rapid growth in the next few years. It will grow to $5.57 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. Anticipated growth in the forecast period is driven by the escalating prevalence of sleep disorders, enhancements in healthcare infrastructure, supportive governmental policies, a growing elderly population, and increasing awareness among consumers regarding health issues. Key trends expected in the forecast period encompass progress in genetic research, technological innovations in diagnostic tools, introduction of innovative drugs and treatment approaches, strategic alliances and partnerships among major market players, and the integration of digital health tools and telemedicine.

The increasing prevalence of obesity is anticipated to drive the growth of the narcolepsy market in the future. Obesity, characterized by an excess accumulation of body fat, poses significant health risks. Sedentary lifestyles, poor dietary habits, and environmental factors promoting calorie-dense food consumption and reduced physical activity contribute to the rising number of obese individuals. This condition can disrupt metabolic and hormonal balances, potentially altering sleep patterns and wakefulness regulation, thus contributing to narcolepsy. For instance, data from March 2022 by the World Health Organization indicated that approximately 1 billion people, including 650 million adults, 340 million teenagers, and 39 million children, were classified as obese, with projections indicating a further increase by 2025, leading to approximately 167 million individuals facing health consequences due to excess weight. Consequently, the growing obesity rates are fueling the expansion of the narcolepsy market.

Key players in the narcolepsy market are intensifying their efforts in developing innovative medications, such as extended-release sodium oxybate, to meet the rising demand for effective therapies. Extended-release sodium oxybate is specifically designed for narcolepsy treatment, offering controlled and sustained release of the medication over an extended period, leading to improved symptom relief and sleep quality for narcolepsy patients. For instance, in June 2023, Avadel Pharmaceuticals plc launched LUMRYZ in the United States, an extended-release sodium oxybate formulation approved by the FDA for cataplexy and excessive daytime sleepiness in adults with narcolepsy. It represents a significant advancement over twice-nightly oxybate products, as it eliminates the need for a second dose during the night, enhancing patient convenience and compliance.

In December 2023, NLS Pharmaceutics AG acquired a dual orexin receptor agonist platform from Aexon Labs Inc., expanding its portfolio for narcolepsy and other neurodegenerative disorders. This strategic move provides NLS Pharmaceutics with the option to license Aexon Labs' assets, including highly selective orexin-1/orexin-2 receptor agonists with global rights. Aexon Labs Inc., a US-based company specializing in narcolepsy and neurodegenerative disease treatments, adds valuable resources and expertise to NLS Pharmaceutics' efforts in addressing these conditions.

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Ono Pharmaceutical Co. Ltd, Lupin Pharmaceuticals, Alkermes, Harmony Biosciences, Arena Pharmaceuticals, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Suven Life Sciences Ltd

North America was the largest region in the narcolepsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the narcolepsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The narcolepsy market consists of revenues earned by entities by providing services such as cognitive behavioral therapy, telemedicine consultations, lifestyle management programs, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The narcolepsy market also includes sales of dietary supplements, Pitolisant, Modafinil, and Armodafinil. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcolepsy Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcolepsy drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcolepsy drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcolepsy drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Narcolepsy With Cataplexy; Narcolepsy Without Cataplexy; Secondary Narcolepsy
2) By Disease: Daytime Extreme Sleepiness; Cataplexia; Other Diseases
3) By Therapeutic: Sodium Oxybate; Central Nervous System Stimulants; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitor; Other Therapeutics
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18933

1. Executive Summary

2. Narcolepsy Drugs Market Characteristics

3. Narcolepsy Drugs Market Trends And Strategies

4. Narcolepsy Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Narcolepsy Drugs Market Size and Growth

5.1. Global Narcolepsy Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Narcolepsy Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Narcolepsy Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Narcolepsy Drugs Market Segmentation

6.1. Global Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
6.2. Global Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Daytime Extreme Sleepiness
Cataplexia
Other Diseases
6.3. Global Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Sodium Oxybate
Central Nervous System Stimulants
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitor
Other Therapeutics

7. Narcolepsy Drugs Market Regional And Country Analysis

7.1. Global Narcolepsy Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Narcolepsy Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Narcolepsy Drugs Market

8.1. Asia-Pacific Narcolepsy Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Narcolepsy Drugs Market

9.1. China Narcolepsy Drugs Market Overview
9.2. China Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Narcolepsy Drugs Market

10.1. India Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Narcolepsy Drugs Market

11.1. Japan Narcolepsy Drugs Market Overview
11.2. Japan Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Narcolepsy Drugs Market

12.1. Australia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Narcolepsy Drugs Market

13.1. Indonesia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Narcolepsy Drugs Market

14.1. South Korea Narcolepsy Drugs Market Overview
14.2. South Korea Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Narcolepsy Drugs Market

15.1. Western Europe Narcolepsy Drugs Market Overview
15.2. Western Europe Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Narcolepsy Drugs Market

16.1. UK Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Narcolepsy Drugs Market

17.1. Germany Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Narcolepsy Drugs Market

18.1. France Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Narcolepsy Drugs Market

19.1. Italy Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Narcolepsy Drugs Market

20.1. Spain Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Narcolepsy Drugs Market

21.1. Eastern Europe Narcolepsy Drugs Market Overview
21.2. Eastern Europe Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Narcolepsy Drugs Market

22.1. Russia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Narcolepsy Drugs Market

23.1. North America Narcolepsy Drugs Market Overview
23.2. North America Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Narcolepsy Drugs Market

24.1. USA Narcolepsy Drugs Market Overview
24.2. USA Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Narcolepsy Drugs Market

25.1. Canada Narcolepsy Drugs Market Overview
25.2. Canada Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Narcolepsy Drugs Market

26.1. South America Narcolepsy Drugs Market Overview
26.2. South America Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Narcolepsy Drugs Market

27.1. Brazil Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Narcolepsy Drugs Market

28.1. Middle East Narcolepsy Drugs Market Overview
28.2. Middle East Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Narcolepsy Drugs Market

29.1. Africa Narcolepsy Drugs Market Overview
29.2. Africa Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Narcolepsy Drugs Market Competitive Landscape And Company Profiles

30.1. Narcolepsy Drugs Market Competitive Landscape
30.2. Narcolepsy Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Sanofi S.A.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Takeda Pharmaceutical Company Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Teva Pharmaceutical Industries Ltd.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Narcolepsy Drugs Market Other Major And Innovative Companies

31.1. UCB SA
31.2. Sun Pharmaceutical Industries Ltd.
31.3. Jazz Pharmaceutical plc
31.4. Ipsen Group
31.5. Lundbeck AS
31.6. Hikma Pharmaceuticals plc
31.7. Lupin Limited
31.8. Viatris Inc.
31.9. Harmony Biosciences Holdings Inc.
31.10. Ligand Pharmaceuticals Incorporated
31.11. Sumitomo Dainippon Pharma Co. Ltd.
31.12. Avadel Pharmaceuticals plc
31.13. Bioprojet Pharma s.a.r.l
31.14. Graymark Healthcare Inc.
31.15. Flamel Technologies SA

32. Global Narcolepsy Drugs Market Competitive Benchmarking

33. Global Narcolepsy Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Narcolepsy Drugs Market

35. Narcolepsy Drugs Market Future Outlook and Potential Analysis

35.1 Narcolepsy Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Narcolepsy Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Narcolepsy Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer